Myopic Choroidal Neovascularisation Clinical Trial
Official title:
Optical Coherence Tomography Angiography Changes in Choroidal Neovascularization in High Myopia
Verified date | April 2024 |
Source | Sohag University |
Contact | Ahmed Hamdy |
Phone | 01287307536 |
fcb9976[@]Gmail.com | |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To Analyze the Ability of Optical Coherence Tomography Angiography ( OCT-A ) to detect the presence of myopic Choroidal Neovascularization and to describe the structural features of Myopic CNV..
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | December 1, 2024 |
Est. primary completion date | September 15, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 10 Years to 75 Years |
Eligibility | Inclusion Criteria: - All Patients with High Myopia ( > -6 D or Axial Length > 26.5 mm ) with Fundoscopic Changes Consistent with CNVM , with Clear Media are Subjected to OCTA Exclusion Criteria: - Patients with Treated CNVs , or with other Causes of CNVs including : Neovascular AMD , Idiopathic CNV , Traumatic , Inflammatory , Neoplastic , Degenerative .. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Sohag University |
Ohno-Matsui K, Ikuno Y, Lai TYY, Gemmy Cheung CM. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Prog Retin Eye Res. 2018 Mar;63:92-106. doi: 10.1016/j.preteyeres.2017.10.005. Epub 2017 Oct 28. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Describing the Choroidal Neovascularization in High Myopic Patients diagnosed by OCTA | Describing the Choroidal Neovascularization in High Myopic Patients diagnosed by OCTA Regarding its Activity .. | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05677685 -
VISUPRIME® Eye Drops
|
N/A | |
Active, not recruiting |
NCT03797547 -
Real Life Study in Myopic Neovascularization
|
||
Completed |
NCT03971162 -
Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization
|
N/A | |
Recruiting |
NCT05494775 -
Effect of Corona Virus on Intravitreal Injections
|
N/A | |
Suspended |
NCT04222842 -
CM082 in Patients With Myopic Choroidal Neovascularization (CNV)
|
Phase 1 |